Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial

Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:11:09.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2; the lapse-in-government funding notice and the prior revision reference (v3.4.1) were removed.
    Difference
    0.3%
    Check dated 2026-02-11T04:46:17.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding notice about site status and that the NIH Clinical Center is open; updated Revision: v3.4.1 and removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T03:30:11.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Results for SANCTUARY (NCT04564339) were posted on 2026-01-22, including Week 26 and Week 50 proteinuria and eGFR outcomes for LN and IgAN cohorts; several previously listed result metrics were removed.
    Difference
    3%
    Check dated 2026-01-28T00:42:44.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays 'Results Submitted' instead of 'No Results Posted' and the revision version updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T01:16:21.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations sections are consolidated under a single 'Locations' heading with updated states/countries; the HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-23T09:22:23.000Z thumbnail image

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.